Drug delivery with living cells.

Area of Science:

• Biomedical Engineering
• Pharmacology
• Synthetic Biology

Background:

• Drug delivery systems have advanced significantly, with cell-based approaches emerging as a promising category.
• Cell-based drug delivery involves encapsulating drugs within or attaching them to cells for in vivo transport.
• Genetic engineering enables cells to produce and secrete therapeutic molecules controllably.

Purpose of the Study:

• To review current cell-based drug delivery strategies.
• To highlight novel applications of living cells in therapeutic delivery.
• To explore the integration of synthetic biology in next-generation cell-based systems.

Main Methods:

• Encapsulation of therapeutic agents within cells.
• Surface attachment of drugs to cells.
• Genetic modification of cells for therapeutic molecule secretion.
• Development of synthetic gene networks for advanced cellular devices.

Main Results:

• Cell-based systems offer versatile platforms for drug and protein delivery.
• Engineered cells can act as localized, controlled sources of therapeutics.
• Synthetic biology enables sophisticated cellular functions for targeted drug delivery.
• These advancements hold potential for treating chronic illnesses.

Conclusions:

• Cell-based drug delivery represents a paradigm shift in administering biological medicines.
• Living cells offer unique advantages as both transport vehicles and production units.
• Future developments integrating synthetic biology will further enhance therapeutic efficacy and control.